EP1178828A4 - "death-domain"enthaltender rezeptor - Google Patents
"death-domain"enthaltender rezeptorInfo
- Publication number
- EP1178828A4 EP1178828A4 EP00932061A EP00932061A EP1178828A4 EP 1178828 A4 EP1178828 A4 EP 1178828A4 EP 00932061 A EP00932061 A EP 00932061A EP 00932061 A EP00932061 A EP 00932061A EP 1178828 A4 EP1178828 A4 EP 1178828A4
- Authority
- EP
- European Patent Office
- Prior art keywords
- domain containing
- death domain
- containing receptor
- methods
- polypeptides
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/2878—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the NGF-receptor/TNF-receptor superfamily, e.g. CD27, CD30, CD40, CD95
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
- A61K39/39533—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals
- A61K39/39541—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals against normal tissues, cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/70578—NGF-receptor/TNF-receptor superfamily, e.g. CD27, CD30, CD40, CD95
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/715—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons
- C07K14/7151—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons for tumor necrosis factor [TNF], for lymphotoxin [LT]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/30—Non-immunoglobulin-derived peptide or protein having an immunoglobulin constant or Fc region, or a fragment thereof, attached thereto
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2799/00—Uses of viruses
- C12N2799/02—Uses of viruses as vector
- C12N2799/021—Uses of viruses as vector for the expression of a heterologous nucleic acid
- C12N2799/026—Uses of viruses as vector for the expression of a heterologous nucleic acid where the vector is derived from a baculovirus
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Immunology (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biophysics (AREA)
- Engineering & Computer Science (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Gastroenterology & Hepatology (AREA)
- Zoology (AREA)
- Toxicology (AREA)
- Cell Biology (AREA)
- Oncology (AREA)
- Microbiology (AREA)
- Biomedical Technology (AREA)
- Hematology (AREA)
- Mycology (AREA)
- Epidemiology (AREA)
- Virology (AREA)
- Communicable Diseases (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US13292299P | 1999-05-06 | 1999-05-06 | |
US132922P | 1999-05-06 | ||
PCT/US2000/012163 WO2000067793A1 (en) | 1999-05-06 | 2000-05-05 | Death domain containing receptor 4 |
Publications (2)
Publication Number | Publication Date |
---|---|
EP1178828A1 EP1178828A1 (de) | 2002-02-13 |
EP1178828A4 true EP1178828A4 (de) | 2004-10-13 |
Family
ID=22456184
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP00932061A Withdrawn EP1178828A4 (de) | 1999-05-06 | 2000-05-05 | "death-domain"enthaltender rezeptor |
Country Status (5)
Country | Link |
---|---|
EP (1) | EP1178828A4 (de) |
JP (1) | JP2002544172A (de) |
AU (1) | AU4984300A (de) |
CA (1) | CA2373063A1 (de) |
WO (1) | WO2000067793A1 (de) |
Families Citing this family (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6455040B1 (en) | 1997-01-14 | 2002-09-24 | Human Genome Sciences, Inc. | Tumor necrosis factor receptor 5 |
EP1012274B2 (de) | 1997-01-28 | 2011-06-15 | Human Genome Sciences, Inc. | "death-domain"-enthaltender rezeptor 4 (dr4), ein mitglied der tnf-rezeptor superfamilie, welcher an trail (apo-2l) bindet |
US8329179B2 (en) | 1997-01-28 | 2012-12-11 | Human Genome Sciences, Inc. | Death domain containing receptor 4 antibodies and methods |
US7279160B2 (en) | 2000-05-02 | 2007-10-09 | The Uab Research Foundation | Combinations of DR5 antibodies and other therapeutic agents |
TWI318983B (en) | 2000-05-02 | 2010-01-01 | Uab Research Foundation | An antibody selective for a tumor necrosis factor-related apoptosis-inducing ligand receptor and uses thereof |
US7476383B2 (en) | 2000-05-02 | 2009-01-13 | The Uab Research Foundation | Antibody selective for DR4 and uses thereof |
CA2447602C (en) * | 2001-05-18 | 2011-11-01 | Kirin Beer Kabushiki Kaisha | Anti-trail-r antibodies |
ES2437992T3 (es) | 2001-05-25 | 2014-01-15 | Human Genome Sciences, Inc. | Anticuerpos que se unen inmunoespecíficamente a los receptores de TRAIL |
WO2003013584A1 (en) * | 2001-08-09 | 2003-02-20 | Genset S.A. | Xafinix agonists and antagonists for use in the treatment of metabolic disorders |
ES2357225T3 (es) * | 2001-11-01 | 2011-04-20 | Uab Research Foundation | Combinaciones de anticuerpos anti-dr5 y anticuerpos anti-dr4 y otros agentes terapéuticos. |
CA2590461A1 (en) * | 2004-12-23 | 2006-06-29 | Laboratoires Serono S.A. | Bcma polypeptides and uses thereof |
AU2006210838B2 (en) | 2005-02-02 | 2011-10-20 | The Uab Research Foundation | Agents and methods related to reducing resistance to apoptosis-inducing death receptor agonists |
US20160067337A1 (en) | 2013-03-14 | 2016-03-10 | Bristol-Myers Squibb Company | Combination of dr5 agonist and anti-pd-1 antagonist and methods of use |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1998032856A1 (en) * | 1997-01-28 | 1998-07-30 | Human Genome Sciences, Inc. | Death domain containing receptor 4 (dr4: death receptor 4), member of the tnf-receptor superfamily and binding to trail (ap02-l) |
WO1999002653A1 (en) * | 1997-07-11 | 1999-01-21 | Trustees Of The University Of Pennsylvania | Nucleic acid encoding a novel chemotherapy-induced protein, and methods of use |
WO1999037684A1 (en) * | 1998-01-26 | 1999-07-29 | Genentech, Inc. | Antibodies to death receptor 4 (dr4) and uses thereof |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4179337A (en) * | 1973-07-20 | 1979-12-18 | Davis Frank F | Non-immunogenic polypeptides |
-
2000
- 2000-05-05 JP JP2000616818A patent/JP2002544172A/ja active Pending
- 2000-05-05 AU AU49843/00A patent/AU4984300A/en not_active Abandoned
- 2000-05-05 EP EP00932061A patent/EP1178828A4/de not_active Withdrawn
- 2000-05-05 WO PCT/US2000/012163 patent/WO2000067793A1/en active Application Filing
- 2000-05-05 CA CA002373063A patent/CA2373063A1/en not_active Abandoned
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1998032856A1 (en) * | 1997-01-28 | 1998-07-30 | Human Genome Sciences, Inc. | Death domain containing receptor 4 (dr4: death receptor 4), member of the tnf-receptor superfamily and binding to trail (ap02-l) |
WO1999002653A1 (en) * | 1997-07-11 | 1999-01-21 | Trustees Of The University Of Pennsylvania | Nucleic acid encoding a novel chemotherapy-induced protein, and methods of use |
WO1999037684A1 (en) * | 1998-01-26 | 1999-07-29 | Genentech, Inc. | Antibodies to death receptor 4 (dr4) and uses thereof |
Non-Patent Citations (5)
Title |
---|
CHANTRY D: "Tumour necrosis factor antagonists", EMERGING DRUGS 1999 UNITED KINGDOM, vol. 4, 1999, pages 5 - 13, XP008033630, ISSN: 1361-9195 * |
DELGADO C ET AL: "RESEARCH ARTICLE. QUANTITATIVE ANALYSIS OF POLYETHYLENE GLYCOL (PEG) IN PEG-MODIFIED PROTEINS/CYTOKINES BY AQUEOUS TWO-PHASE SYSTEMS", JOURNAL OF BIOCHEMICAL AND BIOPHYSICAL METHODS, AMSTERDAM, NL, vol. 29, 1994, pages 237 - 250, XP000974417, ISSN: 0165-022X * |
KIM K H ET AL: "Molecular determinants of response to TRAIL combined with chemotherapy in killing of normal and cancer cells", PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH ANNUAL MEETING, vol. 40, March 1999 (1999-03-01), & 90TH ANNUAL MEETING OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH; PHILADELPHIA, PENNSYLVANIA, USA; APRIL 10-14, 1999, pages 486, XP008033656, ISSN: 0197-016X * |
MARSTERS S A ET AL: "Control of apoptosis signaling by Apo2 ligand.", RECENT PROGRESS IN HORMONE RESEARCH. 1999, vol. 54, 1999, pages 225 - 234, XP008033658, ISSN: 0079-9963 * |
See also references of WO0067793A1 * |
Also Published As
Publication number | Publication date |
---|---|
EP1178828A1 (de) | 2002-02-13 |
WO2000067793A8 (en) | 2001-05-25 |
CA2373063A1 (en) | 2000-11-16 |
WO2000067793A9 (en) | 2002-04-18 |
WO2000067793A1 (en) | 2000-11-16 |
AU4984300A (en) | 2000-11-21 |
JP2002544172A (ja) | 2002-12-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CA2285040A1 (en) | Death domain containing receptor 5 | |
AU6250098A (en) | Death domain containing receptor 4 (dr4: death receptor 4), member of the tnf-receptor superfamily and binding to trail (ap02-l) | |
WO1998030694A3 (en) | TUMOR NECROSIS FACTOR RECEPTORS 6α AND 6$g(b) | |
WO1998030693A3 (en) | Tumor necrosis factor receptor 5 | |
EP1003767A4 (de) | Menschlicher tumornekrosefaktor-rezeptor tr10 | |
WO1998031806A3 (en) | Fc receptors and polypeptides | |
WO1998031818A3 (en) | Tace-like and matrilysin-like polypeptides | |
AU9482498A (en) | Interleukin-17 receptor-like protein | |
WO2001055310A8 (en) | Nucleic acids, proteins, and antibodies | |
WO2001054472A8 (en) | Nucleic acids, proteins, and antibodies | |
WO2000066156A8 (en) | Death domain containing receptor 5 | |
WO2000067793A8 (en) | Death domain containing receptor 4 | |
WO2000054651A3 (en) | Human tumor necrosis factor receptor-like genes | |
WO1998027932A3 (en) | Cerebellum and embryo specific protein | |
EP1187842A4 (de) | Der tr10 rezeptor des menschlichen tumor-nekrose-faktors | |
WO2001055168A8 (en) | Nucleic acids, proteins and antibodies | |
WO1998025957A3 (en) | Human prt1-like subunit protein (hprt1) and human eif4g-like protein (p97) genes | |
WO2001005834A9 (en) | Human tumor necrosis factor receptors tr13 and tr14 | |
WO2002018622A3 (en) | TUMOR NECROSIS FACTOR RECEPTORS 6α AND 6$g(b) | |
WO2002057421A3 (en) | Human tumor necrosis factor receptors tr13 and tr14 | |
WO2001055167A8 (en) | Nucleic acids, proteins, and antibodies | |
EP1712631A3 (de) | Fc Rezeptoren | |
WO2001055162A8 (en) | Nucleic acids, proteins, and antibodies |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
17P | Request for examination filed |
Effective date: 20011206 |
|
AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE |
|
AX | Request for extension of the european patent |
Free format text: AL;LT;LV;MK;RO;SI |
|
A4 | Supplementary search report drawn up and despatched |
Effective date: 20040830 |
|
17Q | First examination report despatched |
Effective date: 20050614 |
|
17Q | First examination report despatched |
Effective date: 20050614 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION HAS BEEN WITHDRAWN |
|
18W | Application withdrawn |
Effective date: 20100906 |